Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy

[1]  M. Rogawski,et al.  GluR5 Kainate Receptors, Seizures, and the Amygdala , 2003, Annals of the New York Academy of Sciences.

[2]  R. Mattson,et al.  Topiramate, carbamazepine and valproate monotherapy: double‐blind comparison in newly diagnosed epilepsy , 2003, Acta neurologica Scandinavica.

[3]  E. Ben-Menachem,et al.  Novel Mechanisms of Action of Three Antiepileptic Drugs, Vigabatrin, Tiagabine, and Topiramate , 2003, Neurochemical Research.

[4]  G. Gessa,et al.  In vitro evidence for the presence of [3H]‐haloperidol uptake in rat brain , 2003, British journal of pharmacology.

[5]  A. Nehlig,et al.  Effects of Topiramate in Two Models of Genetically Determined Generalized Epilepsy, the GAERS and the Audiogenic Wistar AS , 2003, Epilepsia.

[6]  P. Veggiotti,et al.  Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study , 2002, Epilepsy Research.

[7]  Yi Zhang,et al.  Mutations in High-Voltage-Activated Calcium Channel Genes Stimulate Low-Voltage-Activated Currents in Mouse Thalamic Relay Neurons , 2002, The Journal of Neuroscience.

[8]  R. Felix.  Insights from Mouse Models of Absence Epilepsy into Ca2+ Channel Physiology and Disease Etiology , 2002, Cellular and Molecular Neurobiology.

[9]  A. Casini,et al.  Sulfonamides and sulfonylated derivatives as anticancer agents. , 2002, Current cancer drug targets.

[10]  W. Turski,et al.  AMPA and GABA(B) receptor antagonists and their interaction in rats with a genetic form of absence epilepsy. , 2001, European journal of pharmacology.

[11]  D. Limbrick,et al.  Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. , 2001, Cell calcium.

[12]  M. Brodie.  Management Strategies for Refractory Localization‐Related Seizures , 2001, Epilepsia.

[13]  G. Coppola,et al.  Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial , 2001, Epilepsy Research.

[14]  G. van Luijtelaar,et al.  Opposite effects of T- and L-type Ca(2+) channels blockers in generalized absence epilepsy. , 2000, European journal of pharmacology.

[15]  Giovambattista De Sarro,et al.  Effects of compounds acting on GABAB receptors in the pentylenetetrazole kindling model of epilepsy in mice , 2000, Neuropharmacology.

[16]  J. L. Stringer.  A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat , 2000, Epilepsy Research.

[17]  J. Bauer,et al.  Topiramat (Topamax®) Pharmakologische Charakteristik und Stellenwert in der aktuellen Epilepsietherapie , 2000, Der Nervenarzt.

[18]  A. Coenen,et al.  Human absence epilepsy: The WAG/Rij rat as a model , 2000 .

[19]  W. Löscher,et al.  Anticonvulsant Efficacy of Topiramate in Phenytoin‐Resistant Kindled Rats , 2000, Epilepsia.

[20]  G. De Sarro,et al.  Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. , 2000, European journal of pharmacology.

[21]  H. White,et al.  Topiramate Modulates GABA‐Evoked Currents in Murine Cortical Neurons by a Nonbenzodiazepine Mechanism , 2000, Epilepsia.

[22]  P. Carlen,et al.  Modulation of High‐Voltage–Activated Calcium Channels in Dentate Granule Cells by Topiramate , 2000, Epilepsia.

[23]  S. Skradski,et al.  Topiramate Blocks Kainate‐Evoked Cobalt Influx into Cultured Neurons , 2000, Epilepsia.

[24]  R. Olsen,et al.  Differential Sensitivity of Recombinant GABAA Receptors Expressed in Xenopus Oocytes to Modulation by Topiramate , 2000, Epilepsia.

[25]  R. Shank,et al.  Effects of Topiramate on Kainate‐ and Domoate‐Activated [14C]Guanidinium Ion Flux Through GluR6 Channels in Transfected BHK Cells Using Cytostar‐T Scintillating Microplates , 2000, Epilepsia.

[26]  S. Sombati,et al.  Effects of Topiramate on Sustained Repetitive Firing and Spontaneous Recurrent Seizure Discharges in Cultured Hippocampal Neurons , 2000, Epilepsia.

[27]  R. Shank,et al.  An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action , 2000, Epilepsia.

[28]  S. Sombati,et al.  Cellular Actions of Topiramate: Blockade of Kainate‐Evoked Inward Currents in Cultured Hippocampal Neurons , 2000, Epilepsia.

[29]  B. Meldrum,et al.  Basic Mechanisms of Gabitril (Tiagabine) and Future Potential Developments , 1999, Epilepsia.

[30]  D. Hosford,et al.  Decreased uptake in P/Q-type calcium channels in homozygous lethargic (Cacnb4lh) mice is associated with increased β3 and decreased β4 calcium channel subunit mRNA expression , 1999 .

[31]  G. De Sarro,et al.  Effects of Novel 6-Desfluoroquinolones and Classic Quinolones on Pentylenetetrazole-Induced Seizures in Mice , 1999, Antimicrobial Agents and Chemotherapy.

[32]  G. De Sarro,et al.  Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects. , 1999, International journal of antimicrobial agents.

[33]  G. De Sarro,et al.  Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats. , 1999, European journal of pharmacology.

[34]  G. Avanzini,et al.  Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. , 1999, The Journal of pharmacology and experimental therapeutics.

[35]  P. Zapater,et al.  Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice , 1998, Brain Research.

[36]  M. Avoli,et al.  Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells , 1997, Neuroscience Letters.

[37]  D. Hosford,et al.  Utility of the Lethargic (lh/lh) Mouse Model of Absence Seizures in Predicting the Effects of Lamotrigine, Vigabatrin, Tiagabine, Gabapentin, and Topiramate Against Human Absence Seizures , 1997, Epilepsia.

[38]  A. Wauquier,et al.  Topiramate: a potent anticonvulsant in the amygdala-kindled rat , 1996, Epilepsy Research.

[39]  E. Ongini,et al.  Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. , 1994, European journal of pharmacology.

[40]  T. Serikawa,et al.  Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. , 1994, European journal of pharmacology.

[41]  C. B. Davis,et al.  Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant , 1994, Epilepsia.

[42]  Jacques Duysens,et al.  Thalamic multiple-unit activity underlying spike-wave discharges in anesthetized rats , 1993, Brain Research.

[43]  G. De Sarro,et al.  Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice. , 1992, General pharmacology.

[44]  B. Meldrum,et al.  Excitatory neurotransmitters in the lateral habenula and pedunculopontine nucleus of rat modulate limbic seizures induced by pilocarpine , 1992, Brain Research.

[45]  W. A. Wilson,et al.  The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. , 1992, Science.

[46]  G. Nisticó,et al.  Anticonvulsant effects of some calcium entry blockers in DBA/2 mice , 1988, British journal of pharmacology.

[47]  R. Shank,et al.  Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compounds. , 1987, Journal of medicinal chemistry.

[48]  A. Coenen,et al.  Two types of electrocortical paroxysms in an inbred strain of rats , 1986, Neuroscience Letters.

[49]  G. Nisticó,et al.  Anticonvulsant properties of flunarizine on reflex and generalized models of epilepsy , 1986, Neuropharmacology.

[50]  J. Millichap,et al.  Mechanism of the anticonvulsant action of acetazoleamide, a carbonic anhydrase inhibitor. , 1955, The Journal of pharmacology and experimental therapeutics.

[51]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[52]  R. Kaminski,et al.  Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice , 2005, Journal of Neural Transmission.

[53]  M. Rogawski.  Principles of Antiepileptic Drug Action , 2002 .

[54]  M. Seldin,et al.  Studies of the lethargic (lh/lh) mouse model of absence seizures: regulatory mechanisms and identification of the lh gene. , 1999, Advances in neurology.

[55]  B. Meldrum,et al.  Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically epilepsy prone rats. , 1990, General pharmacology.